We are live on
!
Find out more
PA
Pinnacle Associates Portfolio holdings
AUM
$7.78B
1-Year Est. Return
45.07%
This Fund
S&P 500
This Quarter
Est. Return
+14.33%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$6.91B
AUM Growth
+$82.5M
(+1.2%)
Cap. Flow
-$567M
Cap. Flow
% of AUM
-8.2%
Top 10 Holdings %
Top 10 Hldgs %
24.12%
Holding
865
New
42
Increased
270
Reduced
470
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$34.6M |
| 2 |
Walmart Inc
WMT
|
+$12.2M |
| 3 |
NVIDIA
NVDA
|
+$8.11M |
| 4 |
Evolus
EOLS
|
+$7.02M |
| 5 |
AbbVie
ABBV
|
+$6.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$335M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$17.9M |
| 3 |
Royal Caribbean
RCL
|
+$12.1M |
| 4 |
Golar LNG
GLNG
|
+$12M |
| 5 |
Apple
AAPL
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.46% |
| 2 | Financials | 11.35% |
| 3 | Healthcare | 9.92% |
| 4 | Industrials | 8.66% |
| 5 | Communication Services | 7.24% |
Similar funds
EHC
IMCOOI
PGFC
WRCM
BCWM
WF
SIAU
BFM
Pinnacle Associates's Q2 2025 Portfolio in Review
As of Q2 2025, Pinnacle Associates held 865 positions worth $6.91B, up 1.2% from $6.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Pinnacle Associates withdrew a net $567M in Q2 2025, closing 20 positions and reducing 470 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $17.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Pinnacle Associates opened a new position in Evolus worth $6.32M.
- Pinnacle Associates's largest Q2 2025 buy was Evolus: 685,960 shares worth $6.32M.
- Pinnacle Associates added most to Vanguard Total Stock Market ETF in Q2 2025, an estimated $34.6M increase.
- Pinnacle Associates's biggest Q2 2025 reduction was Johnson & Johnson, cutting an estimated $335M.
- Pinnacle Associates fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $17.9M.
- Pinnacle Associates's ten largest holdings make up 24% of its $6.91B portfolio in Q2 2025.
- Pinnacle Associates opened 42 new positions and closed 20 in Q2 2025.
- Pinnacle Associates's portfolio value rose 1.2% quarter-over-quarter to $6.91B.
Based on Pinnacle Associates's 13F filing for Q2 2025, filed 4 Aug 2025.